000 | 01816 a2200493 4500 | ||
---|---|---|---|
005 | 20250517102654.0 | ||
264 | 0 | _c20170530 | |
008 | 201705s 0 0 eng d | ||
022 | _a1535-5667 | ||
024 | 7 |
_a10.2967/jnumed.115.169888 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKlein Hesselink, Esther N | |
245 | 0 | 0 |
_aEffects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study. _h[electronic resource] |
260 |
_bJournal of nuclear medicine : official publication, Society of Nuclear Medicine _cNov 2016 |
||
300 |
_a1685-1691 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study | ||
650 | 0 | 4 | _aCausality |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 |
_aIodine Radioisotopes _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNetherlands _xepidemiology |
650 | 0 | 4 |
_aOrgans at Risk _xradiation effects |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aRadiation Injuries _xdiagnosis |
650 | 0 | 4 |
_aRadiopharmaceuticals _xtherapeutic use |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aThyroid Neoplasms _xepidemiology |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aXerostomia _xdiagnosis |
700 | 1 | _aBrouwers, Adrienne H | |
700 | 1 | _ade Jong, Johan R | |
700 | 1 | _avan der Horst-Schrivers, Anouk N A | |
700 | 1 | _aCoppes, Rob P | |
700 | 1 | _aLefrandt, Joop D | |
700 | 1 | _aJager, Piet L | |
700 | 1 | _aVissink, Arjan | |
700 | 1 | _aLinks, Thera P | |
773 | 0 |
_tJournal of nuclear medicine : official publication, Society of Nuclear Medicine _gvol. 57 _gno. 11 _gp. 1685-1691 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2967/jnumed.115.169888 _zAvailable from publisher's website |
999 |
_c26157172 _d26157172 |